Today’s Watch List : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Oracle Corporation (NYSE:ORCL), JGWPT Holdings Inc. (NYSE:JGW), Argan, Inc. (NYSE:AGX), The Allstate Corporation (NYSE:ALL)

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced updated clinical results on its investigational tyrosine kinase inhibitor (TKI), AP26113, in patients with advanced non-small cell lung cancer (NSCLC) from an ongoing Phase 1/2 trial. These study results show sustained anti-tumor activity of AP26113 in patients with anaplastic lymphoma kinase (ALK) positive NSCLC, including patients with active brain metastases. The updated Phase 1/2 trial now contains more mature data of AP26113, including increasing depth and durability of response in ALK+ NSCLC patients, as well as additional safety data. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its eekly performance is -3.05%. On last trading day company shares ended up $5.40. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -7.43%.

Larry Ellison was the main draw for tens of thousands of technology professionals at Oracle Corporation (NYSE:ORCL)’s annual conference in San Francisco on Tuesday, where he joked about losing his name after relinquishing his role as the company’s CEO. Oracle Corporation (NYSE:ORCL) shares decreased -0.42% in last trading session and ended the day at $38.28. ORCL Gross Margin is 81.10% and its return on assets is 12.10%. Oracle Corporation (NYSE:ORCL) quarterly performance is -5.83%.

Zacks upgraded shares of JGWPT Holdings (NYSE:JGW) from a neutral rating to an outperform rating in a research report sent to investors on Wednesday morning. The firm currently has $14.10 price target on the stock. On 30 September, JGWPT Holdings Inc. (NYSE:JGW) shares moved up 1.14% and was closed at $12.39. JGW EPS growth in last 5 year was 0.00%. JGWPT Holdings Inc. (NYSE:JGW) year to date (YTD) performance is -28.75%.

Argan, Inc. (NYSE:AGX) announced that Arthur Trudel will retire as Chief Financial Officer and Senior Vice President in January 2015. Cynthia Flanders, a member of Argan’s board of directors, will succeed Trudel as CFO. Trudel has been Argan’s CFO since joining the Company in April 2003. Argan, Inc. (NYSE:AGX) ended the last trading day at $33.38. Company weekly volatility is calculated as 3.57% and price to cash ratio as 1.40. Argan, Inc. (NYSE:AGX) showed a weekly performance of -4.33%.

Zacks reissued their neutral rating on shares of The Allstate (NYSE:ALL) in a research report sent to investors on Tuesday morning. They currently have a $64.00 price target on the stock. The Allstate Corporation (NYSE:ALL) shares moved up 0.13% in last trading session and ended the day at $61.37. ALL return on assets is 1.90%. The Allstate Corporation (NYSE:ALL) quarterly performance is 4.28%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone